var eventsData = [{"Ticker":"CME","EffectiveDate":"2017-02-02","Type":"EarningsRevenueBeat","Title":"Before market open, CME reports 2016 Q4's earning $1.14 per share and revenue $912.9MM. This beats analyst's estimated EPS $1.11, beats estimated revenue $903.79MM.","DailyReturn":0.002978,"FiveDayReturnAfter":-0.036472,"FiveDayReturnBefore":0.006223},{"Ticker":"CME","EffectiveDate":"2016-12-23","Type":"Dividend","Title":"The Firm pays dividend $3.25","DailyReturn":-0.004428,"FiveDayReturnAfter":-0.017957,"FiveDayReturnBefore":-0.013497},{"Ticker":"CME","EffectiveDate":"2016-12-07","Type":"Dividend","Title":"The Firm pays dividend $0.6","DailyReturn":0.019831,"FiveDayReturnAfter":0.040762,"FiveDayReturnBefore":0.055499},{"Ticker":"CME","EffectiveDate":"2016-11-14","Type":"RatingNeutral","Title":"JP Morgan downgrades CME to Neutral from Overweight.","DailyReturn":0.01259,"FiveDayReturnAfter":-0.003941,"FiveDayReturnBefore":0.106255},{"Ticker":"CME","EffectiveDate":"2016-11-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.045089,"FiveDayReturnAfter":0.027216,"FiveDayReturnBefore":0.1015},{"Ticker":"CME","EffectiveDate":"2016-11-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.045089,"FiveDayReturnAfter":0.027216,"FiveDayReturnBefore":0.1015},{"Ticker":"CME","EffectiveDate":"2016-11-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.017986,"FiveDayReturnAfter":0.1015,"FiveDayReturnBefore":-0.016174},{"Ticker":"CME","EffectiveDate":"2016-11-03","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.017986,"FiveDayReturnAfter":0.1015,"FiveDayReturnBefore":-0.016174},{"Ticker":"CME","EffectiveDate":"2016-11-03","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.017986,"FiveDayReturnAfter":0.1015,"FiveDayReturnBefore":-0.016174},{"Ticker":"CME","EffectiveDate":"2016-10-27","Type":"RevenueBeat","Title":"Before market open, CME reports 2016 Q3's earning $1.05 per share and revenue $841.7MM. This meets analyst's estimated EPS $1.05, misses estimated revenue $847.76MM.","DailyReturn":-0.026449,"FiveDayReturnAfter":-0.016174,"FiveDayReturnBefore":-0.010543},{"Ticker":"CME","EffectiveDate":"2016-10-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.026449,"FiveDayReturnAfter":-0.016174,"FiveDayReturnBefore":-0.010543},{"Ticker":"CME","EffectiveDate":"2016-10-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.026449,"FiveDayReturnAfter":-0.016174,"FiveDayReturnBefore":-0.010543},{"Ticker":"CME","EffectiveDate":"2016-10-05","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $116; previously $115.","DailyReturn":0.001251,"FiveDayReturnAfter":0.0,"FiveDayReturnBefore":-0.016981},{"Ticker":"CME","EffectiveDate":"2016-09-07","Type":"Dividend","Title":"The Firm pays dividend $0.6","DailyReturn":-0.002708,"FiveDayReturnAfter":0.006328,"FiveDayReturnBefore":0.003254},{"Ticker":"CME","EffectiveDate":"2016-08-31","Type":"RatingNeutral","Title":"Jefferies maintains CME to Buy. Target Price is $118; previously $112.","DailyReturn":0.004729,"FiveDayReturnAfter":-0.004012,"FiveDayReturnBefore":0.016927},{"Ticker":"CME","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $112; previously $111.","DailyReturn":0.011513,"FiveDayReturnAfter":-0.000388,"FiveDayReturnBefore":0.013835},{"Ticker":"CME","EffectiveDate":"2016-07-29","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $111; previously $110.","DailyReturn":0.002943,"FiveDayReturnAfter":0.013835,"FiveDayReturnBefore":0.008967},{"Ticker":"CME","EffectiveDate":"2016-07-29","Type":"RatingNeutral","Title":"UBS maintains CME to Buy. Target Price is $114; previously $104.","DailyReturn":0.002943,"FiveDayReturnAfter":0.013835,"FiveDayReturnBefore":0.008967},{"Ticker":"CME","EffectiveDate":"2016-07-29","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $100; previously $99.","DailyReturn":0.002943,"FiveDayReturnAfter":0.013835,"FiveDayReturnBefore":0.008967},{"Ticker":"CME","EffectiveDate":"2016-07-29","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $103; previously $99.","DailyReturn":0.002943,"FiveDayReturnAfter":0.013835,"FiveDayReturnBefore":0.008967},{"Ticker":"CME","EffectiveDate":"2016-07-29","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Overweight. Target Price is $106; previously $99.","DailyReturn":0.002943,"FiveDayReturnAfter":0.013835,"FiveDayReturnBefore":0.008967},{"Ticker":"CME","EffectiveDate":"2016-07-28","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CME reports 2016 Q2's earning $1.14 per share and revenue $906.4MM. This beats analyst's estimated EPS $1.11, misses estimated revenue $912.29MM.","DailyReturn":-0.007593,"FiveDayReturnAfter":0.005341,"FiveDayReturnBefore":0.012145},{"Ticker":"CME","EffectiveDate":"2016-07-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.007593,"FiveDayReturnAfter":0.005341,"FiveDayReturnBefore":0.012145},{"Ticker":"CME","EffectiveDate":"2016-07-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.007593,"FiveDayReturnAfter":0.005341,"FiveDayReturnBefore":0.012145},{"Ticker":"CME","EffectiveDate":"2016-07-14","Type":"RatingNeutral","Title":"CLSA maintains CME to Underperform. Target Price is $100; previously $95.","DailyReturn":0.01605,"FiveDayReturnAfter":0.017796,"FiveDayReturnBefore":0.015874},{"Ticker":"CME","EffectiveDate":"2016-06-08","Type":"Dividend","Title":"The Firm pays dividend $0.6","DailyReturn":-0.000524,"FiveDayReturnAfter":-0.006517,"FiveDayReturnBefore":-0.019079},{"Ticker":"CME","EffectiveDate":"2016-05-20","Type":"RatingNeutral","Title":"Sterne Agee CRT initiates coverage on CME to Neutral. Target Price is $90.","DailyReturn":0.006995,"FiveDayReturnAfter":0.017491,"FiveDayReturnBefore":0.007125},{"Ticker":"CME","EffectiveDate":"2016-05-18","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.024884,"FiveDayReturnAfter":0.036492,"FiveDayReturnBefore":-0.003171},{"Ticker":"CME","EffectiveDate":"2016-05-03","Type":"RatingNeutral","Title":"Buckingham Research initiates coverage on CME to Buy. Target Price is $105.","DailyReturn":-0.008438,"FiveDayReturnAfter":0.004051,"FiveDayReturnBefore":-0.000855},{"Ticker":"CME","EffectiveDate":"2016-04-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.022549,"FiveDayReturnAfter":-0.022915,"FiveDayReturnBefore":0.014501},{"Ticker":"CME","EffectiveDate":"2016-04-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.022549,"FiveDayReturnAfter":-0.022915,"FiveDayReturnBefore":0.014501},{"Ticker":"CME","EffectiveDate":"2016-04-28","Type":"RevenueBeat","Title":"Before market open, CME reports 2016 Q1's earning $1.15 per share and revenue $934.2MM. This meets analyst's estimated EPS $1.15, misses estimated revenue $942.43MM.","DailyReturn":-0.022549,"FiveDayReturnAfter":-0.022915,"FiveDayReturnBefore":0.014501},{"Ticker":"CME","EffectiveDate":"2016-04-08","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $98; previously $97.","DailyReturn":-0.033941,"FiveDayReturnAfter":-0.013647,"FiveDayReturnBefore":-0.040692},{"Ticker":"CME","EffectiveDate":"2016-04-06","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.001587,"FiveDayReturnAfter":-0.048552,"FiveDayReturnBefore":-0.00496},{"Ticker":"CME","EffectiveDate":"2016-03-11","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Neutral. Target Price is $2.78; previously $2.63.","DailyReturn":0.009175,"FiveDayReturnAfter":0.028296,"FiveDayReturnBefore":-0.000055},{"Ticker":"CME","EffectiveDate":"2016-03-08","Type":"Dividend","Title":"The Firm pays dividend $0.6","DailyReturn":0.003334,"FiveDayReturnAfter":0.036018,"FiveDayReturnBefore":0.023133},{"Ticker":"CME","EffectiveDate":"2016-02-09","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $110; previously $106.","DailyReturn":0.034594,"FiveDayReturnAfter":0.005749,"FiveDayReturnBefore":0.008351},{"Ticker":"CME","EffectiveDate":"2016-02-08","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $97; previously $100.","DailyReturn":0.018521,"FiveDayReturnAfter":0.02894,"FiveDayReturnBefore":-0.014574},{"Ticker":"CME","EffectiveDate":"2016-02-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.025715,"FiveDayReturnAfter":0.034049,"FiveDayReturnBefore":-0.008765},{"Ticker":"CME","EffectiveDate":"2016-02-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.025715,"FiveDayReturnAfter":0.034049,"FiveDayReturnBefore":-0.008765},{"Ticker":"CME","EffectiveDate":"2016-01-26","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $105; previously $104.","DailyReturn":0.02044,"FiveDayReturnAfter":0.055162,"FiveDayReturnBefore":-0.000827},{"Ticker":"CME","EffectiveDate":"2016-01-13","Type":"RatingUpgrade","Title":"JP Morgan upgrades CME to Overweight from Neutral.","DailyReturn":-0.035301,"FiveDayReturnAfter":-0.035583,"FiveDayReturnBefore":-0.024007},{"Ticker":"CME","EffectiveDate":"2016-01-06","Type":"RatingNeutral","Title":"Credit Suisse maintains CME to Neutral. Target Price is $100; previously $94.","DailyReturn":-0.004923,"FiveDayReturnAfter":-0.024007,"FiveDayReturnBefore":-0.027807},{"Ticker":"CME","EffectiveDate":"2015-12-23","Type":"Dividend","Title":"The Firm pays dividend $2.9","DailyReturn":-0.008716,"FiveDayReturnAfter":-0.002947,"FiveDayReturnBefore":-0.004847},{"Ticker":"CME","EffectiveDate":"2015-12-08","Type":"Dividend","Title":"The Firm pays dividend $0.5","DailyReturn":-0.012419,"FiveDayReturnAfter":-0.044915,"FiveDayReturnBefore":0.019169},{"Ticker":"CME","EffectiveDate":"2015-12-08","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on CME to Underperform. Target Price is $83.","DailyReturn":-0.012419,"FiveDayReturnAfter":-0.044915,"FiveDayReturnBefore":0.019169},{"Ticker":"CME","EffectiveDate":"2015-11-11","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.00256,"FiveDayReturnAfter":-0.0252,"FiveDayReturnBefore":0.016937},{"Ticker":"CME","EffectiveDate":"2015-11-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00256,"FiveDayReturnAfter":-0.0252,"FiveDayReturnBefore":0.016937},{"Ticker":"CME","EffectiveDate":"2015-11-05","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.001258,"FiveDayReturnAfter":0.025973,"FiveDayReturnBefore":-0.00575},{"Ticker":"CME","EffectiveDate":"2015-11-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.001258,"FiveDayReturnAfter":0.025973,"FiveDayReturnBefore":-0.00575},{"Ticker":"CME","EffectiveDate":"2015-11-05","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.001258,"FiveDayReturnAfter":0.025973,"FiveDayReturnBefore":-0.00575},{"Ticker":"CME","EffectiveDate":"2015-10-30","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $98; previously $100.","DailyReturn":-0.030281,"FiveDayReturnAfter":-0.019801,"FiveDayReturnBefore":0.052255},{"Ticker":"CME","EffectiveDate":"2015-10-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.015426,"FiveDayReturnAfter":-0.00575,"FiveDayReturnBefore":0.060143},{"Ticker":"CME","EffectiveDate":"2015-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.015426,"FiveDayReturnAfter":-0.00575,"FiveDayReturnBefore":0.060143},{"Ticker":"CME","EffectiveDate":"2015-10-08","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $98; previously $102.","DailyReturn":-0.008932,"FiveDayReturnAfter":-0.037867,"FiveDayReturnBefore":-0.022353},{"Ticker":"CME","EffectiveDate":"2015-09-08","Type":"Dividend","Title":"The Firm pays dividend $0.5","DailyReturn":0.031437,"FiveDayReturnAfter":0.026938,"FiveDayReturnBefore":-0.023418},{"Ticker":"CME","EffectiveDate":"2015-09-04","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Neutral. Target Price is $97; previously $99.","DailyReturn":-0.014711,"FiveDayReturnAfter":0.012541,"FiveDayReturnBefore":0.000426},{"Ticker":"CME","EffectiveDate":"2015-08-11","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $100; previously $96.","DailyReturn":-0.007653,"FiveDayReturnAfter":0.002549,"FiveDayReturnBefore":0.010568},{"Ticker":"CME","EffectiveDate":"2015-07-31","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $102; previously $100.","DailyReturn":-0.009999,"FiveDayReturnAfter":0.000825,"FiveDayReturnBefore":0.004028},{"Ticker":"CME","EffectiveDate":"2015-07-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.0,"FiveDayReturnAfter":0.009031,"FiveDayReturnBefore":-0.0197},{"Ticker":"CME","EffectiveDate":"2015-07-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.0,"FiveDayReturnAfter":0.009031,"FiveDayReturnBefore":-0.0197},{"Ticker":"CME","EffectiveDate":"2015-07-10","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $96; previously $87.","DailyReturn":0.015881,"FiveDayReturnAfter":0.022434,"FiveDayReturnBefore":0.034196},{"Ticker":"CME","EffectiveDate":"2015-07-06","Type":"RatingNeutral","Title":"UBS maintains CME to Buy. Target Price is $108; previously $105.","DailyReturn":0.003288,"FiveDayReturnAfter":0.043994,"FiveDayReturnBefore":0.002868},{"Ticker":"CME","EffectiveDate":"2015-06-17","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $98; previously $92.","DailyReturn":-0.000829,"FiveDayReturnAfter":-0.018189,"FiveDayReturnBefore":0.002385},{"Ticker":"CME","EffectiveDate":"2015-06-08","Type":"Dividend","Title":"The Firm pays dividend $0.5","DailyReturn":-0.002933,"FiveDayReturnAfter":0.015388,"FiveDayReturnBefore":0.018407},{"Ticker":"CME","EffectiveDate":"2015-06-05","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Neutral. Target Price is $92; previously $93.","DailyReturn":0.018145,"FiveDayReturnAfter":0.053187,"FiveDayReturnBefore":0.002231},{"Ticker":"CME","EffectiveDate":"2015-05-28","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.001598,"FiveDayReturnAfter":0.006794,"FiveDayReturnBefore":-0.011964},{"Ticker":"CME","EffectiveDate":"2015-05-20","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.011262,"FiveDayReturnAfter":-0.011964,"FiveDayReturnBefore":-0.000421},{"Ticker":"CME","EffectiveDate":"2015-05-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.011262,"FiveDayReturnAfter":-0.011964,"FiveDayReturnBefore":-0.000421},{"Ticker":"CME","EffectiveDate":"2015-05-20","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.011262,"FiveDayReturnAfter":-0.011964,"FiveDayReturnBefore":-0.000421},{"Ticker":"CME","EffectiveDate":"2015-05-08","Type":"RatingUpgrade","Title":"Evercore ISI Group upgrades CME to Buy from Hold.","DailyReturn":0.02132,"FiveDayReturnAfter":0.039157,"FiveDayReturnBefore":0.016258},{"Ticker":"CME","EffectiveDate":"2015-05-08","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $87; previously $89.","DailyReturn":0.02132,"FiveDayReturnAfter":0.039157,"FiveDayReturnBefore":0.016258},{"Ticker":"CME","EffectiveDate":"2015-05-08","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $105; previously $104.","DailyReturn":0.02132,"FiveDayReturnAfter":0.039157,"FiveDayReturnBefore":0.016258},{"Ticker":"CME","EffectiveDate":"2015-05-01","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $89; previously $90.","DailyReturn":-0.00143,"FiveDayReturnAfter":0.016258,"FiveDayReturnBefore":0.006622},{"Ticker":"CME","EffectiveDate":"2015-04-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.01917,"FiveDayReturnAfter":0.012257,"FiveDayReturnBefore":-0.016345},{"Ticker":"CME","EffectiveDate":"2015-04-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.01917,"FiveDayReturnAfter":0.012257,"FiveDayReturnBefore":-0.016345},{"Ticker":"CME","EffectiveDate":"2015-04-10","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $90; previously $91.","DailyReturn":0.01563,"FiveDayReturnAfter":0.007348,"FiveDayReturnBefore":-0.03939},{"Ticker":"CME","EffectiveDate":"2015-03-30","Type":"RatingNeutral","Title":"Jefferies maintains CME to Buy. Target Price is $104; previously $97.","DailyReturn":0.006655,"FiveDayReturnAfter":-0.027416,"FiveDayReturnBefore":-0.052376},{"Ticker":"CME","EffectiveDate":"2015-03-19","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.006869,"FiveDayReturnAfter":-0.048856,"FiveDayReturnBefore":0.027655},{"Ticker":"CME","EffectiveDate":"2015-03-19","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.006869,"FiveDayReturnAfter":-0.048856,"FiveDayReturnBefore":0.027655},{"Ticker":"CME","EffectiveDate":"2015-03-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.006869,"FiveDayReturnAfter":-0.048856,"FiveDayReturnBefore":0.027655},{"Ticker":"CME","EffectiveDate":"2015-03-19","Type":"Item_1.02","Title":"Termination of a Material Definitive Agreement\r\n","DailyReturn":0.006869,"FiveDayReturnAfter":-0.048856,"FiveDayReturnBefore":0.027655},{"Ticker":"CME","EffectiveDate":"2015-03-06","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $106; previously $104.","DailyReturn":-0.009344,"FiveDayReturnAfter":0.010431,"FiveDayReturnBefore":0.008298},{"Ticker":"CME","EffectiveDate":"2015-03-06","Type":"Dividend","Title":"The Firm pays dividend $0.5","DailyReturn":-0.009344,"FiveDayReturnAfter":0.010431,"FiveDayReturnBefore":0.008298},{"Ticker":"CME","EffectiveDate":"2015-03-04","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.006282,"FiveDayReturnAfter":-0.013534,"FiveDayReturnBefore":0.009625},{"Ticker":"CME","EffectiveDate":"2015-03-04","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.006282,"FiveDayReturnAfter":-0.013534,"FiveDayReturnBefore":0.009625},{"Ticker":"CME","EffectiveDate":"2015-03-04","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.006282,"FiveDayReturnAfter":-0.013534,"FiveDayReturnBefore":0.009625},{"Ticker":"CME","EffectiveDate":"2015-03-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.006282,"FiveDayReturnAfter":-0.013534,"FiveDayReturnBefore":0.009625},{"Ticker":"CME","EffectiveDate":"2015-02-06","Type":"RatingNeutral","Title":"Citigroup maintains CME to Buy. Target Price is $100; previously $94.","DailyReturn":0.037098,"FiveDayReturnAfter":0.048034,"FiveDayReturnBefore":0.052198},{"Ticker":"CME","EffectiveDate":"2015-02-06","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $104; previously $102.","DailyReturn":0.037098,"FiveDayReturnAfter":0.048034,"FiveDayReturnBefore":0.052198},{"Ticker":"CME","EffectiveDate":"2015-02-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.017815,"FiveDayReturnAfter":0.060432,"FiveDayReturnBefore":0.046793},{"Ticker":"CME","EffectiveDate":"2015-02-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.017815,"FiveDayReturnAfter":0.060432,"FiveDayReturnBefore":0.046793},{"Ticker":"CME","EffectiveDate":"2015-02-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.022688,"FiveDayReturnAfter":0.08086,"FiveDayReturnBefore":-0.001143},{"Ticker":"CME","EffectiveDate":"2015-01-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $102; previously $101.","DailyReturn":-0.000565,"FiveDayReturnAfter":-0.026891,"FiveDayReturnBefore":0.041024},{"Ticker":"CME","EffectiveDate":"2015-01-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000565,"FiveDayReturnAfter":-0.026891,"FiveDayReturnBefore":0.041024},{"Ticker":"CME","EffectiveDate":"2015-01-23","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.000565,"FiveDayReturnAfter":-0.026891,"FiveDayReturnBefore":0.041024},{"Ticker":"CME","EffectiveDate":"2015-01-20","Type":"RatingUpgrade","Title":"Citigroup upgrades CME to Buy from Neutral. Target Price is $94; previously $88.","DailyReturn":0.005997,"FiveDayReturnAfter":0.043151,"FiveDayReturnBefore":-0.043152},{"Ticker":"CME","EffectiveDate":"2015-01-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.005997,"FiveDayReturnAfter":0.043151,"FiveDayReturnBefore":-0.043152},{"Ticker":"CME","EffectiveDate":"2015-01-15","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.001647,"FiveDayReturnAfter":0.041024,"FiveDayReturnBefore":-0.037971},{"Ticker":"CME","EffectiveDate":"2015-01-07","Type":"RatingNeutral","Title":"Jefferies maintains CME to Buy. Target Price is $97; previously $93.","DailyReturn":0.011571,"FiveDayReturnAfter":-0.001834,"FiveDayReturnBefore":-0.032572},{"Ticker":"CME","EffectiveDate":"2015-01-07","Type":"RatingNeutral","Title":"CLSA downgrades CME to Underperform from Outperform.","DailyReturn":0.011571,"FiveDayReturnAfter":-0.001834,"FiveDayReturnBefore":-0.032572},{"Ticker":"CME","EffectiveDate":"2015-01-05","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.005673,"FiveDayReturnAfter":0.007349,"FiveDayReturnBefore":-0.027308},{"Ticker":"CME","EffectiveDate":"2014-12-24","Type":"Dividend","Title":"The Firm pays dividend $2","DailyReturn":-0.001543,"FiveDayReturnAfter":-0.023082,"FiveDayReturnBefore":0.057945},{"Ticker":"CME","EffectiveDate":"2014-12-12","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $98; previously $96.","DailyReturn":-0.015823,"FiveDayReturnAfter":0.04205,"FiveDayReturnBefore":0.019423},{"Ticker":"CME","EffectiveDate":"2014-12-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.00508,"FiveDayReturnAfter":-0.012268,"FiveDayReturnBefore":0.039413},{"Ticker":"CME","EffectiveDate":"2014-12-08","Type":"Dividend","Title":"The Firm pays dividend $0.47","DailyReturn":0.007477,"FiveDayReturnAfter":-0.013575,"FiveDayReturnBefore":0.047304},{"Ticker":"CME","EffectiveDate":"2014-12-08","Type":"RatingNeutral","Title":"Keefe, Bruyette & Woods downgrades CME to Market Perform from Outperform. Target Price is $92.","DailyReturn":0.007477,"FiveDayReturnAfter":-0.013575,"FiveDayReturnBefore":0.047304},{"Ticker":"CME","EffectiveDate":"2014-12-02","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.011819,"FiveDayReturnAfter":0.055107,"FiveDayReturnBefore":0.017527},{"Ticker":"CME","EffectiveDate":"2014-11-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00583,"FiveDayReturnAfter":-0.001982,"FiveDayReturnBefore":0.047025},{"Ticker":"CME","EffectiveDate":"2014-11-06","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.00583,"FiveDayReturnAfter":-0.001982,"FiveDayReturnBefore":0.047025},{"Ticker":"CME","EffectiveDate":"2014-11-06","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.00583,"FiveDayReturnAfter":-0.001982,"FiveDayReturnBefore":0.047025},{"Ticker":"CME","EffectiveDate":"2014-10-31","Type":"RatingNeutral","Title":"Citigroup maintains CME to Neutral. Target Price is $84; previously $82.","DailyReturn":0.027587,"FiveDayReturnAfter":0.056143,"FiveDayReturnBefore":0.004423},{"Ticker":"CME","EffectiveDate":"2014-10-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.0033,"FiveDayReturnAfter":0.047025,"FiveDayReturnBefore":0.029012},{"Ticker":"CME","EffectiveDate":"2014-10-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.0033,"FiveDayReturnAfter":0.047025,"FiveDayReturnBefore":0.029012},{"Ticker":"CME","EffectiveDate":"2014-10-14","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Buy. Target Price is $96; previously $95.","DailyReturn":0.010632,"FiveDayReturnAfter":0.004797,"FiveDayReturnBefore":-0.029186},{"Ticker":"CME","EffectiveDate":"2014-10-08","Type":"RatingNeutral","Title":"Bank of America maintains CME to Neutral. Target Price is $82; previously $76.","DailyReturn":0.01768,"FiveDayReturnAfter":0.001254,"FiveDayReturnBefore":-0.002631},{"Ticker":"CME","EffectiveDate":"2014-10-07","Type":"RatingNeutral","Title":"Citigroup maintains CME to Neutral. Target Price is $82; previously $73.","DailyReturn":-0.019668,"FiveDayReturnAfter":-0.029186,"FiveDayReturnBefore":0.023002},{"Ticker":"CME","EffectiveDate":"2014-10-02","Type":"RatingNeutral","Title":"Credit Suisse maintains CME to Neutral. Target Price is $83; previously $74.","DailyReturn":0.012846,"FiveDayReturnAfter":0.021923,"FiveDayReturnBefore":-0.023402},{"Ticker":"CME","EffectiveDate":"2014-09-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.005786,"FiveDayReturnAfter":0.023002,"FiveDayReturnBefore":-0.03789},{"Ticker":"CME","EffectiveDate":"2014-09-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.005786,"FiveDayReturnAfter":0.023002,"FiveDayReturnBefore":-0.03789},{"Ticker":"CME","EffectiveDate":"2014-09-18","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains CME to Outperform. Target Price is $90; previously $80.","DailyReturn":0.028132,"FiveDayReturnAfter":0.007285,"FiveDayReturnBefore":0.059751},{"Ticker":"CME","EffectiveDate":"2014-09-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00436,"FiveDayReturnAfter":0.053887,"FiveDayReturnBefore":-0.007873},{"Ticker":"CME","EffectiveDate":"2014-09-10","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on CME to Buy. Target Price is $85.","DailyReturn":0.00436,"FiveDayReturnAfter":0.053887,"FiveDayReturnBefore":-0.007873},{"Ticker":"CME","EffectiveDate":"2014-09-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.00436,"FiveDayReturnAfter":0.053887,"FiveDayReturnBefore":-0.007873},{"Ticker":"CME","EffectiveDate":"2014-09-08","Type":"Dividend","Title":"The Firm pays dividend $0.47","DailyReturn":-0.000526,"FiveDayReturnAfter":0.043147,"FiveDayReturnBefore":-0.001699},{"Ticker":"CME","EffectiveDate":"2014-08-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.010553,"FiveDayReturnAfter":0.022324,"FiveDayReturnBefore":0.020242},{"Ticker":"CME","EffectiveDate":"2014-08-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.010553,"FiveDayReturnAfter":0.022324,"FiveDayReturnBefore":0.020242},{"Ticker":"CME","EffectiveDate":"2014-08-01","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $75; previously $76.","DailyReturn":0.003246,"FiveDayReturnAfter":-0.009786,"FiveDayReturnBefore":-0.019023},{"Ticker":"CME","EffectiveDate":"2014-07-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.024924,"FiveDayReturnAfter":-0.029985,"FiveDayReturnBefore":0.012607},{"Ticker":"CME","EffectiveDate":"2014-07-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.024924,"FiveDayReturnAfter":-0.029985,"FiveDayReturnBefore":0.012607},{"Ticker":"CME","EffectiveDate":"2014-07-30","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.004371,"FiveDayReturnAfter":-0.024809,"FiveDayReturnBefore":0.012394},{"Ticker":"CME","EffectiveDate":"2014-07-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.004371,"FiveDayReturnAfter":-0.024809,"FiveDayReturnBefore":0.012394},{"Ticker":"CME","EffectiveDate":"2014-07-08","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Neutral. Target Price is $68; previously $67.5.","DailyReturn":-0.015109,"FiveDayReturnAfter":-0.011992,"FiveDayReturnBefore":0.024132},{"Ticker":"CME","EffectiveDate":"2014-06-30","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $77; previously $75.","DailyReturn":0.007526,"FiveDayReturnAfter":0.024132,"FiveDayReturnBefore":-0.018712},{"Ticker":"CME","EffectiveDate":"2014-06-10","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Neutral. Target Price is $67.5; previously $69.5.","DailyReturn":-0.008214,"FiveDayReturnAfter":0.004098,"FiveDayReturnBefore":-0.012015},{"Ticker":"CME","EffectiveDate":"2014-06-06","Type":"Dividend","Title":"The Firm pays dividend $0.47","DailyReturn":0.011298,"FiveDayReturnAfter":0.026443,"FiveDayReturnBefore":-0.041563},{"Ticker":"CME","EffectiveDate":"2014-05-21","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.021891,"FiveDayReturnAfter":0.048569,"FiveDayReturnBefore":-0.029763},{"Ticker":"CME","EffectiveDate":"2014-05-21","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.021891,"FiveDayReturnAfter":0.048569,"FiveDayReturnBefore":-0.029763},{"Ticker":"CME","EffectiveDate":"2014-05-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.021891,"FiveDayReturnAfter":0.048569,"FiveDayReturnBefore":-0.029763},{"Ticker":"CME","EffectiveDate":"2014-05-20","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.026013,"FiveDayReturnAfter":0.018591,"FiveDayReturnBefore":-0.007929},{"Ticker":"CME","EffectiveDate":"2014-05-14","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.01105,"FiveDayReturnAfter":-0.029763,"FiveDayReturnBefore":0.029324},{"Ticker":"CME","EffectiveDate":"2014-05-09","Type":"RatingNeutral","Title":"Jefferies maintains CME to Buy. Target Price is $84; previously $89.","DailyReturn":0.006072,"FiveDayReturnAfter":0.004471,"FiveDayReturnBefore":-0.021597},{"Ticker":"CME","EffectiveDate":"2014-05-06","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Neutral. Target Price is $69.5; previously $76.5.","DailyReturn":-0.017204,"FiveDayReturnAfter":0.016493,"FiveDayReturnBefore":-0.014235},{"Ticker":"CME","EffectiveDate":"2014-05-02","Type":"RatingNeutral","Title":"Citigroup maintains CME to Hold. Target Price is $73; previously $74.","DailyReturn":-0.015705,"FiveDayReturnAfter":-0.021597,"FiveDayReturnBefore":-0.003107},{"Ticker":"CME","EffectiveDate":"2014-05-02","Type":"RatingNeutral","Title":"UBS maintains CME to Buy. Target Price is $79; previously $83.","DailyReturn":-0.015705,"FiveDayReturnAfter":-0.021597,"FiveDayReturnBefore":-0.003107},{"Ticker":"CME","EffectiveDate":"2014-05-02","Type":"RatingNeutral","Title":"Barclays maintains CME to Equal-Weight. Target Price is $78; previously $82.","DailyReturn":-0.015705,"FiveDayReturnAfter":-0.021597,"FiveDayReturnBefore":-0.003107},{"Ticker":"CME","EffectiveDate":"2014-05-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00412,"FiveDayReturnAfter":-0.000427,"FiveDayReturnBefore":-0.014247},{"Ticker":"CME","EffectiveDate":"2014-05-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.00412,"FiveDayReturnAfter":-0.000427,"FiveDayReturnBefore":-0.014247},{"Ticker":"CME","EffectiveDate":"2014-04-10","Type":"RatingNeutral","Title":"Citigroup maintains CME to Neutral. Target Price is $74; previously $78.","DailyReturn":-0.016683,"FiveDayReturnAfter":-0.011572,"FiveDayReturnBefore":-0.038653},{"Ticker":"CME","EffectiveDate":"2014-04-09","Type":"RatingNeutral","Title":"Citigroup maintains CME to Neutral. Target Price is $74; previously $78.","DailyReturn":0.005786,"FiveDayReturnAfter":-0.019574,"FiveDayReturnBefore":-0.049804},{"Ticker":"CME","EffectiveDate":"2014-03-06","Type":"Dividend","Title":"The Firm pays dividend $0.47","DailyReturn":0.010665,"FiveDayReturnAfter":0.001315,"FiveDayReturnBefore":0.051554},{"Ticker":"CME","EffectiveDate":"2014-03-05","Type":"RatingNeutral","Title":"Compass Point terminates CME coverage  from Neutral; previously $75.","DailyReturn":0.005526,"FiveDayReturnAfter":0.004984,"FiveDayReturnBefore":0.036718},{"Ticker":"CME","EffectiveDate":"2014-02-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000679,"FiveDayReturnAfter":0.039163,"FiveDayReturnBefore":0.005585},{"Ticker":"CME","EffectiveDate":"2014-02-05","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.000679,"FiveDayReturnAfter":0.039163,"FiveDayReturnBefore":0.005585},{"Ticker":"CME","EffectiveDate":"2014-02-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.005876,"FiveDayReturnAfter":0.032005,"FiveDayReturnBefore":0.003421},{"Ticker":"CME","EffectiveDate":"2014-02-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.005876,"FiveDayReturnAfter":0.032005,"FiveDayReturnBefore":0.003421},{"Ticker":"CME","EffectiveDate":"2014-01-28","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Neutral. Target Price is $76.5; previously $75.5.","DailyReturn":0.003702,"FiveDayReturnAfter":0.003421,"FiveDayReturnBefore":-0.034498},{"Ticker":"CME","EffectiveDate":"2014-01-08","Type":"RatingNeutral","Title":"Citigroup downgrades CME to Neutral from Buy. Target Price is $82.","DailyReturn":-0.009766,"FiveDayReturnAfter":-0.033051,"FiveDayReturnBefore":-0.007935},{"Ticker":"CME","EffectiveDate":"2013-12-24","Type":"Dividend","Title":"The Firm pays dividend $2.6","DailyReturn":-0.006085,"FiveDayReturnAfter":-0.025916,"FiveDayReturnBefore":0.009185},{"Ticker":"CME","EffectiveDate":"2013-12-06","Type":"Dividend","Title":"The Firm pays dividend $0.45","DailyReturn":0.016654,"FiveDayReturnAfter":0.018266,"FiveDayReturnBefore":-0.039653},{"Ticker":"CME","EffectiveDate":"2013-11-07","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.000937,"FiveDayReturnAfter":0.050873,"FiveDayReturnBefore":-0.002938},{"Ticker":"CME","EffectiveDate":"2013-11-07","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.000937,"FiveDayReturnAfter":0.050873,"FiveDayReturnBefore":-0.002938},{"Ticker":"CME","EffectiveDate":"2013-11-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000937,"FiveDayReturnAfter":0.050873,"FiveDayReturnBefore":-0.002938},{"Ticker":"CME","EffectiveDate":"2013-11-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.01178,"FiveDayReturnAfter":0.040791,"FiveDayReturnBefore":-0.02381},{"Ticker":"CME","EffectiveDate":"2013-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.01178,"FiveDayReturnAfter":0.040791,"FiveDayReturnBefore":-0.02381},{"Ticker":"CME","EffectiveDate":"2013-10-21","Type":"RatingNeutral","Title":"Compass Point maintains CME to Neutral. Target Price is $75; previously $70.","DailyReturn":-0.002473,"FiveDayReturnAfter":-0.004304,"FiveDayReturnBefore":0.027447},{"Ticker":"CME","EffectiveDate":"2013-09-25","Type":"RatingUpgrade","Title":"Keefe Bruyette & Woods upgrades CME to Outperform from Market Perform. Target Price is $89; previously $81.","DailyReturn":0.02095,"FiveDayReturnAfter":0.023948,"FiveDayReturnBefore":0.0149},{"Ticker":"CME","EffectiveDate":"2013-09-06","Type":"Dividend","Title":"The Firm pays dividend $0.45","DailyReturn":-0.00672,"FiveDayReturnAfter":-0.002746,"FiveDayReturnBefore":0.03608},{"Ticker":"CME","EffectiveDate":"2013-09-04","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.01825,"FiveDayReturnAfter":0.018518,"FiveDayReturnBefore":0.005407},{"Ticker":"CME","EffectiveDate":"2013-09-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.01825,"FiveDayReturnAfter":0.018518,"FiveDayReturnBefore":0.005407},{"Ticker":"CME","EffectiveDate":"2013-09-04","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.01825,"FiveDayReturnAfter":0.018518,"FiveDayReturnBefore":0.005407},{"Ticker":"CME","EffectiveDate":"2013-08-02","Type":"RatingNeutral","Title":"UBS maintains CME to Buy. Target Price is $83; previously $84.","DailyReturn":0.001801,"FiveDayReturnAfter":0.000692,"FiveDayReturnBefore":-0.022876},{"Ticker":"CME","EffectiveDate":"2013-08-01","Type":"EarningsRevenueBeat","Title":"Before market open, CME reports 2013 Q2's earning $0.93 per share and revenue $816.1MM. This beats analyst's estimated EPS $0.88, beats estimated revenue $803.79MM.","DailyReturn":-0.02552,"FiveDayReturnAfter":-0.029878,"FiveDayReturnBefore":0.005823},{"Ticker":"CME","EffectiveDate":"2013-08-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.02552,"FiveDayReturnAfter":-0.029878,"FiveDayReturnBefore":0.005823},{"Ticker":"CME","EffectiveDate":"2013-08-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.02552,"FiveDayReturnAfter":-0.029878,"FiveDayReturnBefore":0.005823},{"Ticker":"CME","EffectiveDate":"2013-07-02","Type":"RatingNeutral","Title":"Raymond James downgrades CME to Market Perform from Outperform; previously $72.","DailyReturn":-0.017122,"FiveDayReturnAfter":0.00248,"FiveDayReturnBefore":0.005899},{"Ticker":"CME","EffectiveDate":"2013-06-25","Type":"RatingUpgrade","Title":"JP Morgan upgrades CME to Neutral from Underweight. Target Price is $72; previously $52.5.","DailyReturn":0.004207,"FiveDayReturnAfter":0.005899,"FiveDayReturnBefore":-0.00433},{"Ticker":"CME","EffectiveDate":"2013-06-24","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CME to Neutral from Sell.","DailyReturn":-0.009506,"FiveDayReturnAfter":-0.010998,"FiveDayReturnBefore":0.033097},{"Ticker":"CME","EffectiveDate":"2013-06-14","Type":"RatingUpgrade","Title":"ISI Group upgrades CME to Buy from Neutral. Target Price is $80; previously $70.","DailyReturn":0.002023,"FiveDayReturnAfter":0.039018,"FiveDayReturnBefore":0.073009},{"Ticker":"CME","EffectiveDate":"2013-06-11","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.008492,"FiveDayReturnAfter":0.045255,"FiveDayReturnBefore":0.066348},{"Ticker":"CME","EffectiveDate":"2013-06-06","Type":"Dividend","Title":"The Firm pays dividend $0.45","DailyReturn":0.001453,"FiveDayReturnAfter":0.049054,"FiveDayReturnBefore":0.024108},{"Ticker":"CME","EffectiveDate":"2013-06-04","Type":"RatingUpgrade","Title":"Wells Fargo upgrades CME to Outperform from Market Perform.","DailyReturn":0.005817,"FiveDayReturnAfter":0.066348,"FiveDayReturnBefore":0.063482},{"Ticker":"CME","EffectiveDate":"2013-06-03","Type":"RatingNeutral","Title":"Jefferies maintains CME to Buy. Target Price is $78; previously $69.","DailyReturn":0.012366,"FiveDayReturnAfter":0.064707,"FiveDayReturnBefore":0.057565},{"Ticker":"CME","EffectiveDate":"2013-05-31","Type":"RatingUpgrade","Title":"Keefe Bruyette & Woods upgrades CME to Market Perform from Underperform.","DailyReturn":-0.026512,"FiveDayReturnAfter":-0.005883,"FiveDayReturnBefore":0.101102},{"Ticker":"CME","EffectiveDate":"2013-05-22","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.019434,"FiveDayReturnAfter":0.050034,"FiveDayReturnBefore":0.00953},{"Ticker":"CME","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"Macquarie downgrades CME to Neutral from Outperform. Target Price is $60; previously $69.","DailyReturn":-0.014404,"FiveDayReturnAfter":0.003519,"FiveDayReturnBefore":0.037312},{"Ticker":"CME","EffectiveDate":"2013-05-03","Type":"RatingNeutral","Title":"Compass Point maintains CME to Neutral. Target Price is $60; previously $55.","DailyReturn":0.003973,"FiveDayReturnAfter":0.005942,"FiveDayReturnBefore":-0.010377},{"Ticker":"CME","EffectiveDate":"2013-05-02","Type":"EarningsRelease","Title":"Before market open, CME reports 2013 Q1's earning $0.73 per share and revenue $718.6MM. This meets analyst's estimated EPS $0.73, beats estimated revenue $711.88MM.","DailyReturn":0.00449,"FiveDayReturnAfter":0.009434,"FiveDayReturnBefore":-0.000665},{"Ticker":"CME","EffectiveDate":"2013-05-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.00449,"FiveDayReturnAfter":0.009434,"FiveDayReturnBefore":-0.000665},{"Ticker":"CME","EffectiveDate":"2013-05-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00449,"FiveDayReturnAfter":0.009434,"FiveDayReturnBefore":-0.000665},{"Ticker":"CME","EffectiveDate":"2013-04-17","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.012111,"FiveDayReturnAfter":0.006875,"FiveDayReturnBefore":-0.008542},{"Ticker":"CME","EffectiveDate":"2013-04-17","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.012111,"FiveDayReturnAfter":0.006875,"FiveDayReturnBefore":-0.008542},{"Ticker":"CME","EffectiveDate":"2013-04-15","Type":"RatingNeutral","Title":"Jefferies maintains CME to Buy. Target Price is $69; previously $65.","DailyReturn":-0.027116,"FiveDayReturnAfter":-0.024604,"FiveDayReturnBefore":0.017344},{"Ticker":"CME","EffectiveDate":"2013-04-02","Type":"RatingNeutral","Title":"Credit Suisse downgrades CME to Neutral from Overweight. Target Price is $58.","DailyReturn":-0.005416,"FiveDayReturnAfter":-0.011223,"FiveDayReturnBefore":-0.01126},{"Ticker":"CME","EffectiveDate":"2013-03-06","Type":"Dividend","Title":"The Firm pays dividend $0.45","DailyReturn":0.013567,"FiveDayReturnAfter":0.021347,"FiveDayReturnBefore":0.04395},{"Ticker":"CME","EffectiveDate":"2013-03-05","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Underweight. Target Price is $53; previously $51.","DailyReturn":0.012319,"FiveDayReturnAfter":0.03503,"FiveDayReturnBefore":0.052261},{"Ticker":"CME","EffectiveDate":"2013-02-26","Type":"RatingNeutral","Title":"Bank of America assumes CME to Neutral. Target Price is $60.","DailyReturn":0.020768,"FiveDayReturnAfter":0.052261,"FiveDayReturnBefore":-0.012726},{"Ticker":"CME","EffectiveDate":"2013-02-26","Type":"RatingNeutral","Title":"Bank of America assumes CME to Neutral.","DailyReturn":0.020768,"FiveDayReturnAfter":0.052261,"FiveDayReturnBefore":-0.012726},{"Ticker":"CME","EffectiveDate":"2013-02-05","Type":"EarningsRevenueMiss","Title":"After market close, CME reports 2012 Q4's earning $0.63 per share and revenue $660.9MM. This misses analyst's estimated EPS $0.64, misses estimated revenue $664.16MM.","DailyReturn":0.015443,"FiveDayReturnAfter":-0.023435,"FiveDayReturnBefore":0.010694},{"Ticker":"CME","EffectiveDate":"2013-02-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.015443,"FiveDayReturnAfter":-0.023435,"FiveDayReturnBefore":0.010694},{"Ticker":"CME","EffectiveDate":"2013-02-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.015443,"FiveDayReturnAfter":-0.023435,"FiveDayReturnBefore":0.010694},{"Ticker":"CME","EffectiveDate":"2013-01-09","Type":"RatingNeutral","Title":"Compass Point initiates coverage on CME to Neutral. Target Price is $55.","DailyReturn":-0.000756,"FiveDayReturnAfter":0.034192,"FiveDayReturnBefore":0.04307},{"Ticker":"CME","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods downgrades CME to Underperform from Market Perform.","DailyReturn":0.000391,"FiveDayReturnAfter":0.003705,"FiveDayReturnBefore":-0.047016},{"Ticker":"CME","EffectiveDate":"2012-12-13","Type":"Dividend","Title":"The Firm pays dividend $1.3","DailyReturn":-0.005631,"FiveDayReturnAfter":0.021706,"FiveDayReturnBefore":-0.027462},{"Ticker":"CME","EffectiveDate":"2012-12-10","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CME to Sell from Neutral. Target Price is $48.","DailyReturn":-0.016376,"FiveDayReturnAfter":-0.045352,"FiveDayReturnBefore":0.002632},{"Ticker":"CME","EffectiveDate":"2012-12-06","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.014004,"FiveDayReturnAfter":-0.027462,"FiveDayReturnBefore":-0.003284},{"Ticker":"CME","EffectiveDate":"2012-12-06","Type":"Dividend","Title":"The Firm pays dividend $0.45","DailyReturn":0.014004,"FiveDayReturnAfter":-0.027462,"FiveDayReturnBefore":-0.003284},{"Ticker":"CME","EffectiveDate":"2012-12-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.014004,"FiveDayReturnAfter":-0.027462,"FiveDayReturnBefore":-0.003284},{"Ticker":"CME","EffectiveDate":"2012-11-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.002176,"FiveDayReturnAfter":0.006079,"FiveDayReturnBefore":0.013142},{"Ticker":"CME","EffectiveDate":"2012-11-30","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.002176,"FiveDayReturnAfter":0.006079,"FiveDayReturnBefore":0.013142},{"Ticker":"CME","EffectiveDate":"2012-11-30","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.002176,"FiveDayReturnAfter":0.006079,"FiveDayReturnBefore":0.013142},{"Ticker":"CME","EffectiveDate":"2012-11-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.015116,"FiveDayReturnAfter":-0.036842,"FiveDayReturnBefore":-0.006457},{"Ticker":"CME","EffectiveDate":"2012-11-08","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.015116,"FiveDayReturnAfter":-0.036842,"FiveDayReturnBefore":-0.006457},{"Ticker":"CME","EffectiveDate":"2012-11-08","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.015116,"FiveDayReturnAfter":-0.036842,"FiveDayReturnBefore":-0.006457},{"Ticker":"CME","EffectiveDate":"2012-11-07","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.014192,"FiveDayReturnAfter":-0.043695,"FiveDayReturnBefore":0.016997},{"Ticker":"CME","EffectiveDate":"2012-11-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.014192,"FiveDayReturnAfter":-0.043695,"FiveDayReturnBefore":0.016997},{"Ticker":"CME","EffectiveDate":"2012-10-26","Type":"RatingNeutral","Title":"BGB Securities maintains CME to Hold. Target Price is $54; previously $57.","DailyReturn":0.007636,"FiveDayReturnAfter":0.020515,"FiveDayReturnBefore":-0.047231},{"Ticker":"CME","EffectiveDate":"2012-10-26","Type":"RatingNeutral","Title":"Evercore Partners downgrades CME to Equal-Weight from Overweight.","DailyReturn":0.007636,"FiveDayReturnAfter":0.020515,"FiveDayReturnBefore":-0.047231},{"Ticker":"CME","EffectiveDate":"2012-10-26","Type":"RatingUpgrade","Title":"Raymond James upgrades CME to Outperform from Market Perform.","DailyReturn":0.007636,"FiveDayReturnAfter":0.020515,"FiveDayReturnBefore":-0.047231},{"Ticker":"CME","EffectiveDate":"2012-10-26","Type":"RatingNeutral","Title":"UBS maintains CME to Buy. Target Price is $64; previously $66.","DailyReturn":0.007636,"FiveDayReturnAfter":0.020515,"FiveDayReturnBefore":-0.047231},{"Ticker":"CME","EffectiveDate":"2012-10-25","Type":"EarningsRelease","Title":"Before market open, CME reports 2012 Q3's earning $0.66 per share and revenue $653MM..","DailyReturn":-0.027409,"FiveDayReturnAfter":-0.014966,"FiveDayReturnBefore":-0.02342},{"Ticker":"CME","EffectiveDate":"2012-10-22","Type":"RatingNeutral","Title":"Goldman Sachs assumes CME to Neutral. Target Price is $53.","DailyReturn":0.002478,"FiveDayReturnAfter":-0.019301,"FiveDayReturnBefore":0.002304},{"Ticker":"CME","EffectiveDate":"2012-10-08","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades CME to Hold from Buy.","DailyReturn":-0.000174,"FiveDayReturnAfter":-0.020196,"FiveDayReturnBefore":0.004006},{"Ticker":"CME","EffectiveDate":"2012-10-03","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Underweight. Target Price is $55; previously $54.","DailyReturn":-0.0007,"FiveDayReturnAfter":-0.002454,"FiveDayReturnBefore":-0.000176},{"Ticker":"CME","EffectiveDate":"2012-10-01","Type":"RatingNeutral","Title":"Jefferies maintains CME to Buy. Target Price is $65; previously $60.","DailyReturn":-0.003317,"FiveDayReturnAfter":0.004006,"FiveDayReturnBefore":-0.012145},{"Ticker":"CME","EffectiveDate":"2012-09-14","Type":"RatingNeutral","Title":"JP Morgan downgrades CME to Underweight from Neutral. Target Price is $54; previously $56.5.","DailyReturn":-0.007751,"FiveDayReturnAfter":-0.02232,"FiveDayReturnBefore":0.051161},{"Ticker":"CME","EffectiveDate":"2012-09-06","Type":"Dividend","Title":"The Firm pays dividend $0.45","DailyReturn":0.027889,"FiveDayReturnAfter":0.071566,"FiveDayReturnBefore":0.023601},{"Ticker":"CME","EffectiveDate":"2012-09-05","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.0,"FiveDayReturnAfter":0.065609,"FiveDayReturnBefore":0.029542},{"Ticker":"CME","EffectiveDate":"2012-09-05","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.0,"FiveDayReturnAfter":0.065609,"FiveDayReturnBefore":0.029542},{"Ticker":"CME","EffectiveDate":"2012-09-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.0,"FiveDayReturnAfter":0.065609,"FiveDayReturnBefore":0.029542},{"Ticker":"CME","EffectiveDate":"2012-08-17","Type":"RatingNeutral","Title":"UBS maintains CME to Neutral. Target Price is $104; previously $101.","DailyReturn":0.01178,"FiveDayReturnAfter":-0.002808,"FiveDayReturnBefore":-0.000561},{"Ticker":"CME","EffectiveDate":"2012-07-26","Type":"EarningsRelease","Title":"Before market open, CME reports 2012 Q2's earning $0.74 per share and revenue $767MM..","DailyReturn":0.02302,"FiveDayReturnAfter":-0.002931,"FiveDayReturnBefore":-0.02854},{"Ticker":"CME","EffectiveDate":"2012-07-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.02302,"FiveDayReturnAfter":-0.002931,"FiveDayReturnBefore":-0.02854},{"Ticker":"CME","EffectiveDate":"2012-07-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.02302,"FiveDayReturnAfter":-0.002931,"FiveDayReturnBefore":-0.02854},{"Ticker":"CME","EffectiveDate":"2012-06-29","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.013534,"FiveDayReturnAfter":-0.003863,"FiveDayReturnBefore":-0.026266},{"Ticker":"CME","EffectiveDate":"2012-06-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.013534,"FiveDayReturnAfter":-0.003863,"FiveDayReturnBefore":-0.026266},{"Ticker":"CME","EffectiveDate":"2012-06-21","Type":"RatingNeutral","Title":"BGB Securities initiates coverage on CME to Hold.","DailyReturn":-0.020346,"FiveDayReturnAfter":-0.045537,"FiveDayReturnBefore":0.020152},{"Ticker":"CME","EffectiveDate":"2012-06-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.013006,"FiveDayReturnAfter":0.016718,"FiveDayReturnBefore":0.03437},{"Ticker":"CME","EffectiveDate":"2012-06-06","Type":"Dividend","Title":"The Firm pays dividend $0.446","DailyReturn":0.013348,"FiveDayReturnAfter":0.03437,"FiveDayReturnBefore":0.016505},{"Ticker":"CME","EffectiveDate":"2012-05-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.010453,"FiveDayReturnAfter":0.015889,"FiveDayReturnBefore":-0.01266},{"Ticker":"CME","EffectiveDate":"2012-05-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.010453,"FiveDayReturnAfter":0.015889,"FiveDayReturnBefore":-0.01266},{"Ticker":"CME","EffectiveDate":"2012-05-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.014538,"FiveDayReturnAfter":0.013591,"FiveDayReturnBefore":-0.005001},{"Ticker":"CME","EffectiveDate":"2012-05-23","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.014538,"FiveDayReturnAfter":0.013591,"FiveDayReturnBefore":-0.005001},{"Ticker":"CME","EffectiveDate":"2012-05-23","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.014538,"FiveDayReturnAfter":0.013591,"FiveDayReturnBefore":-0.005001},{"Ticker":"CME","EffectiveDate":"2012-05-23","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.014538,"FiveDayReturnAfter":0.013591,"FiveDayReturnBefore":-0.005001},{"Ticker":"CME","EffectiveDate":"2012-05-01","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.009631,"FiveDayReturnAfter":-0.040224,"FiveDayReturnBefore":-0.022615},{"Ticker":"CME","EffectiveDate":"2012-04-27","Type":"RatingNeutral","Title":"JP Morgan maintains CME to Neutral. Target Price is $263; previously $270.","DailyReturn":-0.020511,"FiveDayReturnAfter":-0.036687,"FiveDayReturnBefore":-0.012549},{"Ticker":"CME","EffectiveDate":"2012-04-27","Type":"RatingNeutral","Title":"ISI Group maintains CME to Hold. Target Price is $275; previously $285.","DailyReturn":-0.020511,"FiveDayReturnAfter":-0.036687,"FiveDayReturnBefore":-0.012549},{"Ticker":"CME","EffectiveDate":"2012-04-27","Type":"RatingNeutral","Title":"Jefferies maintains CME to Buy. Target Price is $300; previously $325.","DailyReturn":-0.020511,"FiveDayReturnAfter":-0.036687,"FiveDayReturnBefore":-0.012549},{"Ticker":"CME","EffectiveDate":"2012-04-27","Type":"RatingNeutral","Title":"UBS maintains CME to Buy. Target Price is $300; previously $330.","DailyReturn":-0.020511,"FiveDayReturnAfter":-0.036687,"FiveDayReturnBefore":-0.012549},{"Ticker":"CME","EffectiveDate":"2012-04-26","Type":"EarningsRelease","Title":"Before market open, CME reports 2012 Q1's earning $0.8 per share and revenue $745.5MM..","DailyReturn":0.003149,"FiveDayReturnAfter":-0.037336,"FiveDayReturnBefore":-0.018931},{"Ticker":"CME","EffectiveDate":"2012-04-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.003149,"FiveDayReturnAfter":-0.037336,"FiveDayReturnBefore":-0.018931},{"Ticker":"CME","EffectiveDate":"2012-04-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.003149,"FiveDayReturnAfter":-0.037336,"FiveDayReturnBefore":-0.018931},{"Ticker":"CME","EffectiveDate":"2012-04-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.006531,"FiveDayReturnAfter":-0.027572,"FiveDayReturnBefore":-0.006758},{"Ticker":"CME","EffectiveDate":"2012-04-18","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.006531,"FiveDayReturnAfter":-0.027572,"FiveDayReturnBefore":-0.006758},{"Ticker":"CME","EffectiveDate":"2012-04-12","Type":"RatingNeutral","Title":"Indaba Global Research initiates coverage on CME to Sell. Target Price is $222.","DailyReturn":0.011826,"FiveDayReturnAfter":-0.020516,"FiveDayReturnBefore":-0.014917},{"Ticker":"CME","EffectiveDate":"2012-04-04","Type":"RatingNeutral","Title":"Jefferies maintains CME to Buy. Target Price is $325; previously $305.","DailyReturn":-0.007559,"FiveDayReturnAfter":-0.014917,"FiveDayReturnBefore":-0.019571},{"Ticker":"CME","EffectiveDate":"2012-04-03","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Hold. Target Price is $300; previously $280.","DailyReturn":-0.009683,"FiveDayReturnAfter":-0.031853,"FiveDayReturnBefore":-0.022008},{"Ticker":"CME","EffectiveDate":"2012-03-20","Type":"RatingNeutral","Title":"UBS maintains CME to Buy. Target Price is $330; previously $311.","DailyReturn":0.014998,"FiveDayReturnAfter":0.026068,"FiveDayReturnBefore":0.070857},{"Ticker":"CME","EffectiveDate":"2012-03-16","Type":"RatingNeutral","Title":"Deutsche Bank maintains CME to Hold. Target Price is $280; previously $275.","DailyReturn":0.011179,"FiveDayReturnAfter":0.032649,"FiveDayReturnBefore":0.035632},{"Ticker":"CME","EffectiveDate":"2012-03-12","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.022997,"FiveDayReturnAfter":0.045555,"FiveDayReturnBefore":-0.026867},{"Ticker":"CME","EffectiveDate":"2012-03-07","Type":"Dividend","Title":"The Firm pays dividend $1.046","DailyReturn":0.02043,"FiveDayReturnAfter":0.012124,"FiveDayReturnBefore":-0.056119},{"Ticker":"CME","EffectiveDate":"2012-03-05","Type":"RatingNeutral","Title":"Evercore Partners maintains CME to Equal-Weight. Target Price is $285; previously $250.","DailyReturn":-0.029627,"FiveDayReturnAfter":-0.026867,"FiveDayReturnBefore":-0.009587},{"Ticker":"CME","EffectiveDate":"2012-03-02","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CME to Buy. Target Price is $320; previously $295.","DailyReturn":0.000207,"FiveDayReturnAfter":-0.027854,"FiveDayReturnBefore":-0.00774}];